News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Praill Anthony Scott
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
08/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/29/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/31/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/30/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/17/2020 |
4
| Praill Anthony Scott (CFO) has filed a Form 4 on Kintara Therapeutics, Inc.
Txns:
| Granted 606,557 options to buy
@ $1.7, valued at
$1M
|
|
06/30/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/31/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/01/2019 |
4
| Praill Anthony Scott (CFO) has filed a Form 4 on DelMar Pharmaceuticals, Inc.
Txns:
| Acquired 22 shares
@ $0 |
|
09/09/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/01/2019 |
4
| Praill Anthony Scott (CFO) has filed a Form 4 on DelMar Pharmaceuticals, Inc.
Txns:
| Acquired 22 shares
@ $0 |
|
04/01/2019 |
4
| Praill Anthony Scott (CFO) has filed a Form 4 on DelMar Pharmaceuticals, Inc.
Txns:
| Acquired 211 shares
@ $0.49, valued at
$103.4 |
|
01/02/2019 |
4
| Praill Anthony Scott (CFO) has filed a Form 4 on DelMar Pharmaceuticals, Inc.
Txns:
| Acquired 211 shares
@ $0.3419, valued at
$72.1 |
|
11/13/2018 |
4
| Praill Anthony Scott (CFO) has filed a Form 4 on DelMar Pharmaceuticals, Inc.
Txns:
| Granted 100,000 options to buy
@ $0.6099, valued at
$61k
|
|
10/01/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/03/2018 |
4
| Praill Anthony Scott (CFO) has filed a Form 4 on DelMar Pharmaceuticals, Inc.
Txns:
| Acquired 211 shares
@ $3.2, valued at
$675.2 |
|
04/03/2018 |
4
| Praill Anthony Scott (CFO) has filed a Form 4 on DelMar Pharmaceuticals, Inc.
Txns:
| Acquired 211 shares
@ $3.2, valued at
$675.2 |
|
01/03/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/02/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
06/28/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
06/06/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
04/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
02/22/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
01/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
10/04/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
07/19/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
05/03/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
08/20/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|